

Timothy Kassis
5.9K posts

@TimothyKassis
Co-Founder & CTO @k_dense_ai | Advisor @easyonboarding_ | Ph.D. in Bioengineering. Previously @biostateai, @matterworks_bio, @MIT, @GeorgiaTech.



Meet the 100+ pioneering startups joining the second Gemini Startup Forum. 🌎🛠 On June 16–17 at Google’s Sunnyvale HQ, these global founders will take part in an intensive, two-day summit designed to accelerate the global scale and impact of their AI solutions. Participants will collaborate directly with experts from across @Google to overcome technical hurdles, refine growth strategies, and scale their solutions globally using Google’s premier AI infrastructure. 🚀 Learn more about the cohort: goo.gle/48US2BM

Meet the 100+ pioneering startups joining the second Gemini Startup Forum. 🌎🛠 On June 16–17 at Google’s Sunnyvale HQ, these global founders will take part in an intensive, two-day summit designed to accelerate the global scale and impact of their AI solutions. Participants will collaborate directly with experts from across @Google to overcome technical hurdles, refine growth strategies, and scale their solutions globally using Google’s premier AI infrastructure. 🚀 Learn more about the cohort: goo.gle/48US2BM




OpenShell v0.0.40 🔀 local-domain service routing in the gateway ☸️ k8s node scheduling + tolerations 🔒 CLI TLS now uses the OS trust store 🛡️ SecretResolver debug no longer leaks secrets Two security fixes ship alongside new routing and K8s scheduling control. github.com/NVIDIA/OpenShe…

We're excited to be using Multimodal File Search in K-Dense. Read the blog by @Google on how we are using it to power search: blog.google/innovation-and…



Today marks a pivotal moment for Isomorphic Labs. We have secured $2.1 Billion in our second external funding round, led by Thrive Capital. They are joined at the table by Alphabet, GV and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund. This milestone accelerates our ability to build the pioneering novel AI models that power our AI drug design engine (IsoDDE) and deploy them at scale: delivering scientific breakthroughs with a precision previously thought impossible, accelerating and expanding our pipeline of therapeutic programs toward the clinic. All with the ultimate goal of delivering life-changing new medicines to patients. Moving forward, we will scale our drug candidate pipelines across multiple therapeutic areas, expand our global footprint, and push the boundaries of frontier AI research to power our drug design engine. Deeply grateful to everyone sharing our vision to solve all disease with AI. Let’s build the future of medicine. Read the full announcement here: bit.ly/4v2OI03







We audited 67 public K-Dense Web use cases. Question: what does K-Dense Web + human save versus human alone? Answer: $3.08M of estimated analyst work delivered for $5,670 in credits. Median case: 560x lower cost, 107x faster. Full audit: k-dense.ai/blog/k-dense-w…
